Blocking MUC1 can improve the sensitivity of ovarian cancer cells to paclitaxel and doxorubicin [12], as the anti-apoptotic effects of MUC1 on oxidative stress-induced apoptosis [13,14] and genotoxic agent-induced apoptosis [13,15,16] have been correlated to its chemoresistant mechanisms. The gene discussed is MUC1; the disease is ovarian cancer.